<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Phenylketonuria.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:03 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1247002">
<meta name="Category" content="Concern">
<meta name="Article" content="Phenylketonuria">
<title>Fenilcetonuria-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Fenilcetonuria</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Phenylketonuria.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Diamond A. Evidence for the importance of dopamine for prefrontal cortex
functions early in life. <em>Philos Trans R Soc Lond B Biol Sci</em> 1996;351:1483&#8211;93
[review].</li>

<li class="Ref">Cabalska MB, Nowaczewska I, Sendecka E, Zorska K. Longitudinal study on early
diagnosis and treatment of phenylketonuria in Poland. <em>Eur J Pediatr</em> 1996;155 Suppl
1:S53&#8211;5.</li>

<li class="Ref">Eisensmith RC, Woo SL. Gene therapy for phenylketonuria. <em>Eur J
Pediatr</em> 1996;155 Suppl 1:S16&#8211;9 [review].</li>

<li class="Ref">Lin CM, Tan Y, Lee YM, et al. Expression of human phenylalanine hydroxylase
activity in T lymphocytes of classical phenylketonuria children by retroviral-mediated gene
transfer. <em>J Inherit Metab Dis</em> 1997;20:742&#8211;54.</li>

<li class="Ref">Sarkissian CN, Shao Z, Blain F, et al. A different approach to treatment of
phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. <em>
Proc Natl Acad Sci</em> 1999;96:2339&#8211;44.</li>

<li class="Ref">Pietz J, Kreis R, Rupp A, et al. Large neutral amino acids block phenylalanine
transport into brain tissue in patients with phenylketonuria. <em>J Clin Invest</em>
1999;103:1169&#8211;78.</li>

<li class="Ref">Diamond A. Evidence for the importance of dopamine for prefrontal cortex
functions early in life. <em>Philos Trans R Soc Lond B Biol Sci</em> 1996;351:1483&#8211;93
[review].</li>

<li class="Ref">Cockburn F, Clark BJ. Recommendations for protein and amino acid intake in
phenylketonuric patients. <em>Eur J Pediatr</em> 1996;155 Suppl 1:S125&#8211;9.</li>

<li class="Ref">Koch R, Moseley K, Ning J, et al. Long-term beneficial effects of the
phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuria. <em>Mol
Genet Metab</em> 1999;67:148&#8211;55.</li>

<li class="Ref">Yannicelli S, Ryan A. Improvements in behavior and physical manifestations in
previously untreated adults with phenylketonuria using a phenylalanine-restricted diet: a
national survey. <em>J Inherit Metab Dis</em> 1995;18:131&#8211;4.</li>

<li class="Ref">Williams K. Benefits of normalizing plasma phenylalanine: impact on behavior
and health. A case report. <em>J Inherit Metab Dis</em> 1998;21:785&#8211;90.</li>

<li class="Ref">Arnold G, Kramer BM, Kirby RS, et al. Factors affecting cognitive, motor,
behavioral and executive functioning in children with phenylketonuria. <em>Acta Paediatr</em>
1998;87:565&#8211;70.</li>

<li class="Ref">Baumeister AA, Baumeister AA. Dietary treatment of destructive behavior
associated with hyperphenylalaninemia. <em>Clin Neuropharmacol</em> 1998;21:18&#8211;27
[review].</li>

<li class="Ref">Griffiths P, Ward N, Harvie A, Cockburn F. Neuropsychological outcome of
experimental manipulation of phenylalanine intake in treated phenylketonuria. <em>J Inherit
Metab Dis</em> 1998;21:29&#8211;38.</li>

<li class="Ref">Griffiths P, Smith C, Harvie A. Transitory hyperphenylalaninaemia in children
with continuously treated phenylketonuria. <em>Am J Ment Retard</em>
1997;102:27&#8211;36.</li>

<li class="Ref">Cerone R, Schiaffino MC, Di Stefano S, Veneselli E. Phenylketonuria: diet for
life or not? <em>Acta Paediatrica</em> 1999;88:664&#8211;6.</li>

<li class="Ref">Diamond A, Prevor MB, Callender G, Druin DP. Prefrontal cortex cognitive
deficits in children treated early and continuously for PKU. <em>Monogr Soc Res Child Dev</em>
1997;62:1&#8211;208.</li>

<li class="Ref">Griffiths P, Ward N, Harvie A, Cockburn F. Neuropsychological outcome of
experimental manipulation of phenylalanine intake in treated phenylketonuria. <em>J Inherit
Metab Dis</em> 1998;21:29&#8211;38.</li>

<li class="Ref">Ullrich K. Rationale for the German recommendations for phenylalanine level
control in phenylketonuria 1997. <em>Eur J Pediatr</em> 1999;158:46&#8211;54.</li>

<li class="Ref">Fisch RO, Matalon R, Weisberg S, Michals K. Phenylketonuria: current dietary
treatment practices in the United States and Canada. <em>J Am Coll Nutr</em>
1997;16:147&#8211;51.</li>

<li class="Ref">Riva E, Agostoni C, Biasucci G, et al. Early breastfeeding is linked to higher
intelligence quotient scores in dietary treated phenylketonuric children. <em>Acta
Paediatr</em> 1996;85:56&#8211;8.</li>

<li class="Ref">Sievers E, Arpe T, Schleyerbach U, Schaub J. Molybdenum supplementation in
phenylketonuria diets: adequate in early infancy? <em>J Pediatr Gastroenterol Nutr</em>
2000;31:57&#8211;62.</li>

<li class="Ref">Start K. Treating phenylketonuria by a phenylalanine-free diet. <em>Prof Care
Mother Child</em> 1998;8:109&#8211;10 [review].</li>

<li class="Ref">Davidson PW. Factors affecting cognitive, motor, behavioral and executive
functioning in children with phenylketonuria. <em>Acta Paediatr</em>
1998;87:565&#8211;70.</li>

<li class="Ref">Schulpis KH, Nyalala JO, Papakonstantinou ED, et al. Biotin recycling
impairment in phenylketonuric children with seborrheic dermatitis. <em>Int J Dermatol</em>
1998;37:918&#8211;21.</li>

<li class="Ref">Mackey SA, Berlin CM Jr. Effect of dietary aspartame on plasma concentrations
of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients. <em>Clin
Pediatr</em> 1992;31:394&#8211;9.</li>

<li class="Ref">Waisbren SE, Rokni H, Bailey I, et al. Social factors and the meaning of food
in adherence to medical diets: results of a maternal phenylketonuria summer camp. <em>J
Inherit Metab Dis</em> 1997;20:21&#8211;7.</li>

<li class="Ref">Scheibenreiter S, Tiefenthaler M, Hinteregger V, et al. Austrian report on
longitudinal outcome in phenylketonuria. <em>Eur J Pediatr</em> 1996;155 Suppl
1:S45&#8211;9.</li>

<li class="Ref">Weglage J, Funders B, Ullrich K, et al. Psychosocial aspects in
phenylketonuria. <em>Eur J Pediatr</em> 1996;155 Suppl 1:S101&#8211;4.</li>

<li class="Ref">Brenton DP, Lilburn M. Maternal phenylketonuria. A study from the United
Kingdom. <em>Eur J Pediatr</em> 1996;155 Suppl 1:S177&#8211;80.</li>

<li class="Ref">Levy HL, Ghavami M. Maternal phenylketonuria: a metabolic teratogen. <em>
Teratology</em> 1996;53:176&#8211;84 [review].</li>

<li class="Ref">Cechak P, Hejcmanova L, Rupp A. Long-term follow-up of patients treated for
phenylketonuria (PKU). Results from the Prague PKU Center. <em>Eur J Pediatr</em> 1996;155
Suppl 1:S59&#8211;63.</li>

<li class="Ref">Cipcic-Schmidt S, Trefz FK, Funders B, et al. German Maternal Phenylketonuria
Study. <em>Eur J Pediatr</em> 1996;155 Suppl 1:S173&#8211;6.</li>

<li class="Ref">Rouse B, Azen C, Koch R, et al. Maternal Phenylketonuria Collaborative Study
(MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae. <em>Am J
Med Genet</em> 1997;69:89&#8211;95.</li>

<li class="Ref">Berry HK, Brunner RL, Hunt MM, et al. Valine, isoleucine, and leucine. A new
treatment for phenylketonuria. <em>Am J Dis Child</em> 1990;144:539&#8211;43.</li>

<li class="Ref">Pietz J. Neurological aspects of adult phenylketonuria. <em>Curr Opin
Neurol</em> 1998;11:679&#8211;88 [review].</li>

<li class="Ref">van Spronsen FJ, van Dijk T, Smit GP, et al. Large daily fluctuations in
plasma tyrosine in treated patients with phenylketonuria. <em>Am J Clin Nutr</em>
1996;64:916&#8211;21.</li>

<li class="Ref">Smith ML, Hanley WB, Clarke JT, et al. Randomised controlled trial of tyrosine
supplementation on neuropsychological performance in phenylketonuria. <em>Arch Dis Child</em>
1998;78:116&#8211;21.</li>

<li class="Ref">Tam SY, Roth RH. Mesoprefrontal dopaminergic neurons: can tyrosine
availability influence their functions? <em>Biochem Pharmacol</em> 1997;53:441&#8211;53
[review].</li>

<li class="Ref">Rohr FJ, Lobbregt D, Levy HL. Tyrosine supplementation in the treatment of
maternal phenylketonuria. <em>Am J Clin Nutr</em> 1998;67:473&#8211;6.</li>

<li class="Ref">Wasser S, Ettrich KU, Schmidt KD, et al. Case studies of the effect of
tyrosine administration in children with phenylketonuria on cognitive processes. <em>Klin
Padiatr</em> 1992;204:417&#8211;21 [in German].</li>

<li class="Ref">Smith ML, Hanley WB, Clarke JT, et al. Randomised controlled trial of tyrosine
supplementation on neuropsychological performance in phenylketonuria. <em>Arch Dis Child</em>
1998;78:116&#8211;21.</li>

<li class="Ref">van Spronsen FJ, van Dijk T, Smit GP, et al. Large daily fluctuations in
plasma tyrosine in treated patients with phenylketonuria. <em>Am J Clin Nutr</em>
1996;64:916&#8211;21.</li>

<li class="Ref">Giovannini M, Agostoni C, Biasucci G, et al. Fatty acid metabolism in
phenylketonuria. <em>Eur J Pediatr</em> 1996;155 Suppl 1:S132&#8211;5.</li>

<li class="Ref">Agostoni C, Riva E, Biasucci G, et al. The effects of n-3 and n-6
polyunsaturated fatty acids on plasma lipids and fatty acids of treated phenylketonuric
children. <em>Prostaglandins Leukot Essent Fatty Acids</em> 1995;53:401&#8211;4.</li>

<li class="Ref">Agostoni C, Marangoni F, Riva E, et al. Plasma arachidonic acid and serum
thromboxane B2 concentrations in phenylketonuric children negatively correlate with dietary
compliance. <em>Prostaglandins Leukot Essent Fatty Acids</em> 1997;56:219&#8211;22.</li>

<li class="Ref">Giovannini M, Agostoni C, Biasucci G, et al. Fatty acid metabolism in
phenylketonuria. <em>Eur J Pediatr</em> 1996;155 Suppl 1:S132&#8211;5.</li>

<li class="Ref">Poge AP, Baumann K, Muller E, et al. Long-chain polyunsaturated fatty acids in
plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled
linoleic acid intake. <em>J Inherit Metab Dis</em> 1998;21:373&#8211;81.</li>

<li class="Ref">Jochum F, Terwolbeck K, Meinhold H, et al. Effects of a low selenium state in
patients with phenylketonuria. <em>Acta Paediatr</em> 1997;86:775&#8211;7.</li>

<li class="Ref">Kauf E, Seidel J, Winnefeld K, et al. Selenium in phenylketonuria patients.
Effects of sodium selenite administration. <em>Med Klin</em> 1997;92 Suppl 3:31&#8211;4 [in
German].</li>

<li class="Ref">Sierra C, Vilaseca MA, Moyano D, et al. Antioxidant status in
hyperphenylalaninemia. <em>Clin Chim Acta</em> 1998;276:1&#8211;9.</li>

<li class="Ref">Gropper SS, Naglak MC, Nardella M, et al. Nutrient intakes of adolescents with
phenylketonuria and infants and children with maple syrup urine disease on semisynthetic
diets. <em>J Am Coll Nutr</em> 1993;12:108&#8211;14.</li>

<li class="Ref">Hanley WB, Feigenbaum AS, Clarke JT, et al. Vitamin B12 deficiency in
adolescents and young adults with phenylketonuria. <em>Eur J Pediatr</em> 1996;155 Suppl
1:S145&#8211;7.</li>

<li class="Ref">Schulpis KH, Platokouki H, Papakonstantinou ED, et al. Haemostatic variables
in phenylketonuric children under dietary treatment. <em>J Inherit Metab Dis</em>
1996;19:603&#8211;9.</li>

<li class="Ref">Sierra C, Vilaseca MA, Moyano D, et al. Antioxidant status in
hyperphenylalaninemia. <em>Clin Chim Acta</em> 1998;276:1&#8211;9.</li>

<li class="Ref">Kauf E, Seidel J, Winnefeld K, et al. Selenium in phenylketonuria patients.
Effects of sodium selenite administration. <em>Med Klin</em> 1997;92 Suppl 3:31&#8211;4 [in
German].</li>

<li class="Ref">Lombeck I, Jochum F, Terwolbeck K. Selenium status in infants and children
with phenylketonuria and in maternal phenylketonuria. <em>Eur J Pediatr</em> 1996;155 Suppl
1:S140&#8211;4.</li>

<li class="Ref">Hanley WB, Feigenbaum AS, Clarke JT, et al. Vitamin B12 deficiency in
adolescents and young adults with phenylketonuria. <em>Eur J Pediatr</em> 1996;155 Suppl
1:S145&#8211;7.</li>

<li class="Ref">Schulpis KH, Platokouki H, Papakonstantinou ED, et al. Haemostatic variables
in phenylketonuric children under dietary treatment. <em>J Inherit Metab Dis</em>
1996;19:603&#8211;9.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Phenylketonuria.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:31:03 GMT -->
</html>

